OMO-1 in Solid Malignancies
Clinical trial NCT03138083 · TERMINATED
Trial details
- NCT number
- NCT03138083
- Sponsor
- Octimet Oncology N.V.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-08
- Primary completion
- 2020-05-25
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.